| Neonatal systemic juvenile xanthogranuloma with an ominous presentation and successful treatment. | |
| | |
MedLine Citation:
|
PMID: 21695102 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
This case report originated from a case of neonatal multisystemic juvenile xanthogranuloma (JXG). The patient presented with blue muffin rush, cervical mass, bone destruction, lung nodule, hepatosplenomegaly, and coagulopathy and was successfully treated with Langerhans cell histiocytosis (LCH) based chemotherapy treatment. Similar cases in literature were reviewed and it seems that JXG, a relatively benign entity, when presented in its systemic form with liver involvement, could have an aggressive course and portend quite poor prognosis. Challenges and special consideration of the diagnosis, treatment, and future case observation are discussed. |
| | |
Authors:
|
Rong Fan; Jihong Sun |
Publication Detail:
|
Type: Journal Article Date: 2011-05-22 |
Journal Detail:
|
Title: Clinical Medicine Insights. Oncology Volume: 5 ISSN: 1179-5549 ISO Abbreviation: Clin Med Insights Oncol Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-06-22 Completed Date: 2011-07-14 Revised Date: 2011-08-01 |
Medline Journal Info:
|
Nlm Unique ID: 101525771 Medline TA: Clin Med Insights Oncol Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 157-61 Citation Subset: - |
Affiliation:
|
Riley Hospital for Children at Indiana University Health Department of Pathology 702 Barnhill Drive, Room 2536 Indianapolis, Indiana, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A case of late-onset gemcitabine lung toxicity.
Next Document: TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Respons...